ask="4.60"
ask_size="1000"
average_daily_volume="288038"
bid="4.10"
bid_size="2000"
book_value="0.56"
change="-0.14"
change_from_200_day_moving_average="1.60"
change_from_50_day_moving_average="0.94"
change_from_52_week_high="-0.51"
change_From_52_week_low="2.13"
change_in_percent="-3.23%"
close="4.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="4.34"
high_52_weeks="4.70"
last_trade_date="3/2/2017"
last_trade_price="4.19"
last_trade_size="410"
last_trade_time="4:00pm"
low="4.16"
low_52_weeks="2.06"
market_capitalization="78.30M"
moving_average_200_day="2.59"
moving_average_50_day="3.25"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="4.30"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+61.83%"
percent_change_from_50_day_moving_average="+29.04%"
percent_change_from_52_week_high="-10.85%"
percent_change_from_52_week_low="+103.39%"
previous_close="4.33"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.69"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="7.59"
stock_exchange="NCM"
symbol="BCLI"
volume="115466"
weeks_range_52="2.06 - 4.70"
